434-CT) inhibits Recombinant Human B7‑1/CD80 Fc Chimera (Catalog #
10133-B1) induced IL‑2 secretion in the Jurkat human acute T cell leukemia cell line in a dose-dependent manner (orange line), as measured by the Human IL‑2 Quantikine ELISA Kit (Catalog #
D2050). Inhibition of Recombinant Human B7‑1/CD80 Fc Chimera (3 µg/mL) activity elicited by Recombinant Mouse CTLA‑4 Fc Chimera (1 µg/mL) is neutralized (green line) by increasing concentrations of Mouse CTLA‑4 Monoclonal Antibody (Catalog # MAB434). The ND
50 is typically 2.5-10 µg/mL in the presence of PHA (10 µg/mL)." class="big_lightbox">

434-CT) inhibits Recombinant Human B7‑1/CD80 Fc Chimera (Catalog #
10133-B1) induced IL‑2 secretion in the Jurkat human acute T cell leukemia cell line in a dose-dependent manner (orange line), as measured by the Human IL‑2 Quantikine ELISA Kit (Catalog #
D2050). Inhibition of Recombinant Human B7‑1/CD80 Fc Chimera (3 µg/mL) activity elicited by Recombinant Mouse CTLA‑4 Fc Chimera (1 µg/mL) is neutralized (green line) by increasing concentrations of Mouse CTLA‑4 Monoclonal Antibody (Catalog # MAB434). The ND
50 is typically 2.5-10 µg/mL in the presence of PHA (10 µg/mL)." alt="Recombinant Mouse CTLA‑4 Fc Chimera (Catalog #
434-CT) inhibits Recombinant Human B7‑1/CD80 Fc Chimera (Catalog #
10133-B1) induced IL‑2 secretion in the Jurkat human acute T cell leukemia cell line in a dose-dependent manner (orange line), as measured by the Human IL‑2 Quantikine ELISA Kit (Catalog #
D2050). Inhibition of Recombinant Human B7‑1/CD80 Fc Chimera (3 µg/mL) activity elicited by Recombinant Mouse CTLA‑4 Fc Chimera (1 µg/mL) is neutralized (green line) by increasing concentrations of Mouse CTLA‑4 Monoclonal Antibody (Catalog # MAB434). The ND
50 is typically 2.5-10 µg/mL in the presence of PHA (10 µg/mL)." class="big_thumb" />